OriCell's GPC3 CAR-T Receives NMPA Clearance for Confirmatory Phase II Trial in Late-Line Advanced Hepatocellular Carcinoma

OriCell Therapeutics Holdings Limited ( The Company or Oricell) , announced that its proprietary GPC3-targeted autologous CAR ...